For years, the standard equation for estimating kidney function from a blood test included a coefficient that adjusted the result upward for patients identified as Black — an adjustment built on a generalization about muscle mass and creatinine production, rather than anything measured in the individual patient. In 2021, that changed. Here’s what the new equation does differently, and why it matters.
What eGFR is, and why creatinine stands in for it
Glomerular filtration rate — how much blood the kidneys filter per minute — is the most direct measure of kidney function, but measuring it precisely requires an infusion study that’s impractical for routine care. Creatinine, a muscle-metabolism byproduct cleared almost entirely by the kidneys, is a workable stand-in: measure it in a blood draw, adjust for the factors that affect how much creatinine a person generates in the first place (age and sex, primarily, since both affect muscle mass at a population level), and back-calculate an estimated GFR. That’s what every eGFR equation, including CKD-EPI, actually does.
Why race was in the equation, and why it came out
Earlier CKD-EPI versions included a coefficient that increased the estimated eGFR for patients identified as Black, based on studies suggesting higher average creatinine generation in that population. The trouble is that race is a social and demographic category, not a biological measurement — it doesn’t reliably capture the actual muscle mass or metabolic factors the adjustment was meant to proxy for, and applying it by default to every patient identified as Black, regardless of individual physiology, risked systematically overestimating kidney function in exactly the population already carrying a higher burden of kidney disease.
A joint 2021 task force convened by the National Kidney Foundation and the American Society of Nephrology reviewed the evidence and recommended dropping race from the equation entirely, publishing new coefficients that apply uniformly regardless of race (Inker et al., NEJM 2021). That race-free CKD-EPI 2021 equation is what every modern eGFR calculation uses today.
What actually goes into the calculation
Three inputs: age, sex, and serum creatinine. The equation applies different constants depending on whether a patient’s creatinine sits above or below a sex-specific reference point, then combines that with an age-decay term, since GFR naturally declines with age even in healthy kidneys. Plug in a 60-year-old man with a creatinine of 1.3 mg/dL, for instance, and the equation returns an eGFR of about 63 mL/min/1.73m² — a KDIGO “G2,” or mildly decreased, result.
What a single eGFR result can and can’t tell you
A single low reading is a prompt to look closer, not a diagnosis. KDIGO’s criteria for chronic kidney disease require abnormal kidney function, or a structural marker like albuminuria, to persist for more than three months — a one-off eGFR, however low, needs a repeat measurement and an albuminuria check before it becomes a CKD diagnosis. The equation itself also assumes a stable, steady-state creatinine; it isn’t designed for acute kidney injury, and its accuracy narrows at extremes of muscle mass, in pregnancy, or in patients under 18.
Editverse’s free CKD-EPI 2021 calculator runs the equation instantly from age, sex, and creatinine, maps the result to its KDIGO stage, and walks through this same worked example step by step.
Clinical decision-support aid, not a substitute for clinical judgment. This tool implements a published equation for education and workflow support. It is not a medical device and has not been reviewed by the FDA or any regulatory body; results should always be interpreted by a qualified clinician alongside the full clinical picture.
References
- Inker LA, Eneanya ND, Coresh J, et al. New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race. N Engl J Med. 2021;385(19):1737–1749.
- Delgado C, Baweja M, Crews DC, et al. A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease. Am J Kidney Dis. 2022;79(2):268–288.
- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD. Kidney Int. 2024;105(4S):S117–S314.
NHANES measures serum creatinine in most adult participants, making it a ready-made data source for kidney-function and CKD population-health research. Editverse’s NHANES Study service helps investigators design and execute that analysis end-to-end, from cohort definition through manuscript-ready statistical results.